Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase 2 trial of essential oil blend versus standard topical decolonization for MRSA in surgical oncology patients
2005-002698-65Phase 2Terminated
- Sponsor
- The Christie
- Start
- Mar 2006
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of mupirocin, chlorhexidine and Aquasept in staphylococcal carrier state (2 arms), sponsored by The Christie. Primary endpoint: Safety and clinical efficacy of EOB_71 for MRSA clearance. Started Mar 2006; status: terminated.
02
Drugs
mupirocinchlorhexidineAquasept
03
Conditions
staphylococcal carrier state
Beyond the preview
Go deeper on 2005-002698-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002698-65.